{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:50:39Z","timestamp":1787629839515,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,21]]},"DOI":"10.7759\/cureus.67377","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T02:47:44Z","timestamp":1724294864000},"source":"Crossref","is-referenced-by-count":6,"title":["Advances in Type 1 Diabetes Mellitus Management in Children"],"prefix":"10.7759","author":[{"given":"Mridu","family":"Bahal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineeta","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasleen","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailaja","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Type 1 Diabetes","author":"Lucier J","year":"2024","unstructured":"Lucier J, Weinstock RS. Type 1 Diabetes. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson MA","year":"2014","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014, 383:69-82. 10.1016\/S0140-6736(13)60591-7","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2020-0339","article-title":"Diabetes distress in Indian children with type 1 diabetes mellitus and their mothers","volume":"34","author":"Lohiya NN","year":"2021","unstructured":"Lohiya NN, Kajale NA, Lohiya NN, Khadilkar VV, Gondhalekar K, Khadilkar A. Diabetes distress in Indian children with type 1 diabetes mellitus and their mothers. J Pediatr Endocrinol Metab. 2021, 34:209-16. 10.1515\/jpem-2020-0339","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S006","article-title":"6. Glycemic targets: standards of medical care in diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes-2020. Diabetes Care. 2020, 43:S66-76. 10.2337\/dc20-S006","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan DM","year":"1993","unstructured":"Nathan DM, Genuth S, Lachin J, et al.. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329:977-86. 10.1056\/NEJM199309303291401","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45835","article-title":"Cardiovascular complications of diabetes: from microvascular to macrovascular pathways","volume":"15","author":"Zakir M","year":"2023","unstructured":"Zakir M, Ahuja N, Surksha MA, et al.. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023, 15:e45835. 10.7759\/cureus.45835","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2014.12.004","article-title":"Immunogenetics of type 1 diabetes mellitus","volume":"42","author":"Morran MP","year":"2015","unstructured":"Morran MP, Vonberg A, Khadra A, Pietropaolo M. Immunogenetics of type 1 diabetes mellitus. Mol Aspects Med. 2015, 42:42-60. 10.1016\/j.mam.2014.12.004","journal-title":"Mol Aspects Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.933965","article-title":"Environmental triggering of type 1 diabetes autoimmunity","volume":"13","author":"Houeiss P","year":"2022","unstructured":"Houeiss P, Luce S, Boitard C. Environmental triggering of type 1 diabetes autoimmunity. Front Endocrinol (Lausanne). 2022, 13:933965. 10.3389\/fendo.2022.933965","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00343","article-title":"T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes","volume":"8","author":"Burrack AL","year":"2017","unstructured":"Burrack AL, Martinov T, Fife BT. T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol (Lausanne). 2017, 8:343. 10.3389\/fendo.2017.00343","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","article-title":"Type 1 Diabetes in Children","author":"Los E","year":"2024","unstructured":"Los E, Wilt AS. Type 1 Diabetes in Children. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.34172\/hpp.2020.18","article-title":"Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis","volume":"10","author":"Mobasseri M","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020, 10:98-115. 10.34172\/hpp.2020.18","journal-title":"Health Promot Perspect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13562","article-title":"Epidemiology of type 1 diabetes mellitus in children and adolescents: a 50-year, single-center experience","volume":"16","author":"Kandemir N","year":"2024","unstructured":"Kandemir N, Vuralli D, Ozon A, et al.. Epidemiology of type 1 diabetes mellitus in children and adolescents: a 50-year, single-center experience. J Diabetes. 2024, 16:e13562. 10.1111\/1753-0407.13562","journal-title":"J Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/POC.0000000000000125","article-title":"Type 1 diabetes-a clinical perspective","volume":"16","author":"Kahanovitz L","year":"2017","unstructured":"Kahanovitz L, Sluss PM, Russell SJ. Type 1 diabetes-a clinical perspective. Point Care. 2017, 16:37-40. 10.1097\/POC.0000000000000125","journal-title":"Point Care"},{"key":"ref14","article-title":"Pediatric Diabetic Ketoacidosis","author":"EL-Mohandes N","year":"2024","unstructured":"EL-Mohandes N, Yee G, Bhutta BS, Huecker MR. Pediatric Diabetic Ketoacidosis. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5455\/msm.2023.35.190-195","article-title":"Presence of type 1 diabetes-related autoantibodies in pediatric population in Bosnia and Herzegovina","volume":"35","author":"Zecevic-Pasic L","year":"2023","unstructured":"Zecevic-Pasic L, Tihic-Kapidzic S, Hasanbegovic S, Begovic E, Gojak R, Dzananovic N. Presence of type 1 diabetes-related autoantibodies in pediatric population in Bosnia and Herzegovina. Mater Sociomed. 2023, 35:190-5. 10.5455\/msm.2023.35.190-195","journal-title":"Mater Sociomed"},{"key":"ref16","article-title":"The Management of Type 1 Diabetes","author":"Subramanian S","year":"2000","unstructured":"Subramanian S, Baidal D. The Management of Type 1 Diabetes. Feingold  KR, Anawalt B, Blackman MR, et al. (ed): Endotext, South Dartmouth (MA); 2000."},{"key":"ref17","article-title":"Insulin-Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy","author":"Donnor T","year":"2000","unstructured":"Donnor T, Sarkar S. Insulin-Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy. Feingold KR, Anawalt B, Blackman MR, et al. (ed): Endotext, South Dartmouth (MA); 2000."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4158\/EP10260.RA","article-title":"Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine","volume":"17","author":"Bode BW","year":"2011","unstructured":"Bode BW. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. Endocr Pract. 2011, 17:271-80. 10.4158\/EP10260.RA","journal-title":"Endocr Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/B0-08-045044-X\/00179-6","article-title":"6.19-Diabetes\/syndrome X","author":"Schmeltz L","year":"2007","unstructured":"Schmeltz L, Metzger B. 6.19-Diabetes\/syndrome X. Comprehensive Medicinal Chemistry II. Elsevier, Amsterdam; 2007. 6:417-58. 10.1016\/B0-08-045044-X\/00179-6"},{"key":"ref20","article-title":"NPH Insulin","author":"Saleem F","year":"2024","unstructured":"Saleem F, Sharma A. NPH Insulin. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-39307-2.00031-X","article-title":"31-Insulin, oral hypoglycemics, and glucagon","author":"Galasko GT","year":"2017","unstructured":"Galasko GT. 31-Insulin, oral hypoglycemics, and glucagon. Pharmacology and Therapeutics for Dentistry (Seventh Edition). Dowd FJ, Johnson BS, Mariotti AJ (ed): Mosby, Maryland Heights (MO); 2017. 437-45. 10.1016\/B978-0-323-39307-2.00031-X"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2653","article-title":"Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics","volume":"32","author":"Pozzilli P","year":"2016","unstructured":"Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev. 2016, 32:21-39. 10.1002\/dmrr.2653","journal-title":"Diabetes Metab Res Rev"},{"key":"ref23","article-title":"The Role of Exercise in Diabetes","author":"Zahalka SJ","year":"2000","unstructured":"Zahalka SJ, Abushamat LA, Scalzo RL, Reusch JE. The Role of Exercise in Diabetes . Feingold KR, Anawalt B, Blackman MR, et al. (ed): Endotext, South Dartmouth (MA); 2000."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13699","article-title":"Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with type 1 diabetes","volume":"35","author":"Tel\u00f3 GH","year":"2018","unstructured":"Tel\u00f3 GH, Dougher CE, Volkening LK, Katz ML, Laffel LM. Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with type 1 diabetes. Diabet Med. 2018, 35:1355-63. 10.1111\/dme.13699","journal-title":"Diabet Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0023","article-title":"Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association","volume":"41","author":"Chiang JL","year":"2018","unstructured":"Chiang JL, Maahs DM, Garvey KC, et al.. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care. 2018, 41:2026-44. 10.2337\/dci18-0023","journal-title":"Diabetes Care"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_579_17","article-title":"Emotional and psychological needs of people with diabetes","volume":"22","author":"Kalra S","year":"2018","unstructured":"Kalra S, Jena BN, Yeravdekar R. Emotional and psychological needs of people with diabetes. Indian J Endocrinol Metab. 2018, 22:696-704. 10.4103\/ijem.IJEM_579_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2019.0121","article-title":"Continuous glucose monitoring sensors for diabetes management: a review of technologies and applications","volume":"43","author":"Cappon G","year":"2019","unstructured":"Cappon G, Vettoretti M, Sparacino G, Facchinetti A. Continuous glucose monitoring sensors for diabetes management: a review of technologies and applications. Diabetes Metab J. 2019, 43:383-97. 10.4093\/dmj.2019.0121","journal-title":"Diabetes Metab J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/23743735211056523","article-title":"Benefits and drawbacks of continuous glucose monitoring (CGM) use in young children with type 1 diabetes: a qualitative study from a country where the CGM is not reimbursed","volume":"8","author":"Karaku\u015f KE","year":"2021","unstructured":"Karaku\u015f KE, Sakarya S, Ye\u015filtepe Mutlu G, et al.. Benefits and drawbacks of continuous glucose monitoring (CGM) use in young children with type 1 diabetes: a qualitative study from a country where the CGM is not reimbursed. J Patient Exp. 2021, 8:10.1177\/23743735211056523","journal-title":"J Patient Exp"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2337\/ds18-0091","article-title":"A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy","volume":"32","author":"Berget C","year":"2019","unstructured":"Berget C, Messer LH, Forlenza GP. A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy. Diabetes Spectr. 2019, 32:194-204. 10.2337\/ds18-0091","journal-title":"Diabetes Spectr"},{"key":"ref30","article-title":"Insulin Pump","author":"Yao PY","year":"2024","unstructured":"Yao PY, Ahsun S, Anastasopoulou C, Tadi P. Insulin Pump. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0177","article-title":"Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence","volume":"45","author":"Moon SJ","year":"2021","unstructured":"Moon SJ, Jung I, Park CY. Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence. Diabetes Metab J. 2021, 45:813-39. 10.4093\/dmj.2021.0177","journal-title":"Diabetes Metab J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1558-8","article-title":"Efficacy and safety of the artificial pancreas in the paediatric population with type 1 diabetes","volume":"16","author":"Esposito S","year":"2018","unstructured":"Esposito S, Santi E, Mancini G, et al.. Efficacy and safety of the artificial pancreas in the paediatric population with type 1 diabetes. J Transl Med. 2018, 16:176. 10.1186\/s12967-018-1558-8","journal-title":"J Transl Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073263","article-title":"Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial","volume":"13","author":"Lei M","year":"2023","unstructured":"Lei M, Lin B, Ling P, et al.. Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial. BMJ Open. 2023, 13:e073263. 10.1136\/bmjopen-2023-073263","journal-title":"BMJ Open"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2022.18.1.27","article-title":"Review of automated insulin delivery systems for type 1 diabetes and associated time in range outcomes","volume":"18","author":"Nallicheri A","year":"2022","unstructured":"Nallicheri A, Mahoney KM, Gutow HA, Bellini N, Isaacs D. Review of automated insulin delivery systems for type 1 diabetes and associated time in range outcomes. touchREV Endocrinol. 2022, 18:27-34. 10.17925\/EE.2022.18.1.27","journal-title":"touchREV Endocrinol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00768-3","article-title":"Smartphone-based technology in diabetes management","volume":"11","author":"Doupis J","year":"2020","unstructured":"Doupis J, Festas G, Tsilivigos C, Efthymiou V, Kokkinos A. Smartphone-based technology in diabetes management. Diabetes Ther. 2020, 11:607-19. 10.1007\/s13300-020-00768-3","journal-title":"Diabetes Ther"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.04.002","article-title":"Clinical use of insulin degludec","volume":"109","author":"Vora J","year":"2015","unstructured":"Vora J, Cariou B, Evans M, et al.. Clinical use of insulin degludec. Diabetes Res Clin Pract. 2015, 109:19-31. 10.1016\/j.diabres.2015.04.002","journal-title":"Diabetes Res Clin Pract"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2015.11.005","article-title":"The new long-acting insulin glargine\u00a0U300 achieves an early steady state with low risk of accumulation","volume":"42","author":"Monnier L","year":"2016","unstructured":"Monnier L, Owens DR, Bolli GB. The new long-acting insulin glargine\u00a0U300 achieves an early steady state with low risk of accumulation. Diabetes Metab. 2016, 42:77-9. 10.1016\/j.diabet.2015.11.005","journal-title":"Diabetes Metab"},{"key":"ref38","article-title":"Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors","author":"Padda IS","year":"2024","unstructured":"Padda IS, Mahtani AU, Parmar M. Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref39","article-title":"Glucagon-Like Peptide-1 Receptor Agonists","author":"Collins L","year":"2024","unstructured":"Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-2395","article-title":"Novel once-weekly basal insulin Fc achieved similar glycemic control with a safety profile comparable to insulin degludec in patients with type 1 diabetes","volume":"46","author":"Kazda CM","year":"2023","unstructured":"Kazda CM, Bue-Valleskey JM, Chien J, et al.. Novel once-weekly basal insulin Fc achieved similar glycemic control with a safety profile comparable to insulin degludec in patients with type 1 diabetes. Diabetes Care. 2023, 46:1052-9. 10.2337\/dc22-2395","journal-title":"Diabetes Care"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10520","article-title":"Replenishable prevascularized cell encapsulation devices increase graft survival and function in the subcutaneous space","volume":"8","author":"Chendke GS","year":"2023","unstructured":"Chendke GS, Kharbikar BN, Ashe S, et al.. Replenishable prevascularized cell encapsulation devices increase graft survival and function in the subcutaneous space. Bioeng Transl Med. 2023, 8:e10520. 10.1002\/btm2.10520","journal-title":"Bioeng Transl Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14216","article-title":"The cognitive and psychological effects of living with type 1 diabetes: a narrative review","volume":"37","author":"van Duinkerken E","year":"2020","unstructured":"van Duinkerken E, Snoek FJ, de Wit M. The cognitive and psychological effects of living with type 1 diabetes: a narrative review. Diabet Med. 2020, 37:555-63. 10.1111\/dme.14216","journal-title":"Diabet Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01354","article-title":"Approaches in immunotherapy, regenerative medicine, and bioengineering for type 1 diabetes","volume":"9","author":"Kopan C","year":"2018","unstructured":"Kopan C, Tucker T, Alexander M, Mohammadi MR, Pone EJ, Lakey JR. Approaches in immunotherapy, regenerative medicine, and bioengineering for type 1 diabetes. Front Immunol. 2018, 9:1354. 10.3389\/fimmu.2018.01354","journal-title":"Front Immunol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041189","article-title":"Modulating T cell responses by targeting CD3","volume":"15","author":"Menon AP","year":"2023","unstructured":"Menon AP, Moreno B, Meraviglia-Crivelli D, et al.. Modulating T cell responses by targeting CD3. Cancers (Basel). 2023, 15:1189. 10.3390\/cancers15041189","journal-title":"Cancers (Basel)"},{"key":"ref45","article-title":"Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation","volume":"3","author":"Sageshima J","year":"2009","unstructured":"Sageshima J, Ciancio G, Chen L, Burke GW. Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation. Biol Targets Ther. 2009, 3:319-36.","journal-title":"Biol Targets Ther"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115140","article-title":"Vaccines for immune tolerance against autoimmune disease","volume":"203","author":"Kim A","year":"2023","unstructured":"Kim A, Xie F, Abed OA, Moon JJ. Vaccines for immune tolerance against autoimmune disease. Adv Drug Deliv Rev. 2023, 203:115140. 10.1016\/j.addr.2023.115140","journal-title":"Adv Drug Deliv Rev"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.104045","article-title":"Stem cell therapy for diabetes","volume":"16","author":"Lee KO","year":"2012","unstructured":"Lee KO, Gan SU, Calne RY. Stem cell therapy for diabetes. Indian J Endocrinol Metab. 2012, 16:S227-9. 10.4103\/2230-8210.104045","journal-title":"Indian J Endocrinol Metab"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2020.103386","article-title":"Type 1 diabetes: genes associated with disease development","volume":"45","author":"Klak M","year":"2020","unstructured":"Klak M, Gom\u00f3\u0142ka M, Kowalska P, et al.. Type 1 diabetes: genes associated with disease development. Cent Eur J Immunol. 2020, 45:439-53. 10.5114\/ceji.2020.103386","journal-title":"Cent Eur J Immunol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: a brief overview","volume":"12","author":"Jovic D","year":"2022","unstructured":"Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y. Single-cell RNA sequencing technologies and applications: a brief overview. Clin Transl Med. 2022, 12:e694. 10.1002\/ctm2.694","journal-title":"Clin Transl Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05778-3","article-title":"Precision medicine in type 1 diabetes","volume":"65","author":"Carr AL","year":"2022","unstructured":"Carr AL, Evans-Molina C, Oram RA. Precision medicine in type 1 diabetes. Diabetologia. 2022, 65:1854-66. 10.1007\/s00125-022-05778-3","journal-title":"Diabetologia"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2337\/ds18-0069","article-title":"Smart connected insulin pens, caps, and attachments: a review of the future of diabetes technology","volume":"32","author":"Sangave NA","year":"2019","unstructured":"Sangave NA, Aungst TD, Patel DK. Smart connected insulin pens, caps, and attachments: a review of the future of diabetes technology. Diabetes Spectr. 2019, 32:378-84. 10.2337\/ds18-0069","journal-title":"Diabetes Spectr"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.829565","article-title":"HNF1A\uff1afrom monogenic diabetes to type 2 diabetes and gestational diabetes mellitus","volume":"13","author":"Li LM","year":"2022","unstructured":"Li LM, Jiang BG, Sun LL. HNF1A\uff1afrom monogenic diabetes to type 2 diabetes and gestational diabetes mellitus. Front Endocrinol (Lausanne). 2022, 13:829565. 10.3389\/fendo.2022.829565","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref53","article-title":"Maturity Onset Diabetes in the Young","author":"Hoffman LS","year":"2024","unstructured":"Hoffman LS, Fox TJ, Anastasopoulou C, Jialal I. Maturity Onset Diabetes in the Young. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","volume":"5","author":"Li H","year":"2020","unstructured":"Li H, Yang Y, Hong W, Huang M, Wu M, Zhao X. Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduct Target Ther. 2020, 5:1. 10.1038\/s41392-019-0089-y","journal-title":"Signal Transduct Target Ther"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168875","article-title":"Transcript-targeted therapy based on RNA interference and antisense oligonucleotides: current applications and novel molecular targets","volume":"23","author":"Barresi V","year":"2022","unstructured":"Barresi V, Musmeci C, Rinaldi A, Condorelli DF. Transcript-targeted therapy based on RNA interference and antisense oligonucleotides: current applications and novel molecular targets. Int J Mol Sci. 2022, 23:8875. 10.3390\/ijms23168875","journal-title":"Int J Mol Sci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00864-4","article-title":"Treatment options for MODY patients: a systematic review of literature","volume":"11","author":"Delvecchio M","year":"2020","unstructured":"Delvecchio M, Pastore C, Giordano P. Treatment options for MODY patients: a systematic review of literature. Diabetes Ther. 2020, 11:1667-85. 10.1007\/s13300-020-00864-4","journal-title":"Diabetes Ther"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-1024-2","article-title":"Monogenic diabetes in children and adolescents: recognition and treatment options","volume":"18","author":"Sanyoura M","year":"2018","unstructured":"Sanyoura M, Philipson LH, Naylor R. Monogenic diabetes in children and adolescents: recognition and treatment options. Curr Diab Rep. 2018, 18:58. 10.1007\/s11892-018-1024-2","journal-title":"Curr Diab Rep"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13993","article-title":"Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes","volume":"22","author":"Irace C","year":"2020","unstructured":"Irace C, Cutruzzol\u00e0 A, Nuzzi A, et al.. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes. Diabetes Obes Metab. 2020, 22:1056-61. 10.1111\/dom.13993","journal-title":"Diabetes Obes Metab"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12758","article-title":"Beta-cell replacement strategies for diabetes","volume":"9","author":"Kieffer TJ","year":"2017","unstructured":"Kieffer TJ, Woltjen K, Osafune K, Yabe D, Inagaki N. Beta-cell replacement strategies for diabetes. J Diabetes Investig. 2017, 9:457-63. 10.1111\/jdi.12758","journal-title":"J Diabetes Investig"},{"key":"ref60","article-title":"Afrezza (insulin human) inhalation powder: a new inhaled insulin for the management of type-1 or type-2 diabetes mellitus","volume":"40","author":"Goldberg T","year":"2015","unstructured":"Goldberg T, Wong E. Afrezza (insulin human) inhalation powder: a new inhaled insulin for the management of type-1 or type-2 diabetes mellitus. P T. 2015, 40:735-41.","journal-title":"P T"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1042\/CS20180436","article-title":"Recent developments in genetic\/genomic medicine","volume":"133","author":"Horton RH","year":"2019","unstructured":"Horton RH, Lucassen AM. Recent developments in genetic\/genomic medicine. Clin Sci (Lond). 2019, 133:697-708. 10.1042\/CS20180436","journal-title":"Clin Sci (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280670-advances-in-type-1-diabetes-mellitus-management-in-children","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T02:47:50Z","timestamp":1724294870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280670-advances-in-type-1-diabetes-mellitus-management-in-children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":61,"URL":"https:\/\/doi.org\/10.7759\/cureus.67377","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}